($FEMY) experienced an unprecedented surge, exceeding 600%, driven by the FDA's recent approval of their groundbreaking infertility treatment, FemaSeed. This blog post delves into the remarkable leap, exploring the impact of this innovative treatment on the stock price and the opportunities it has presented to day traders.
With the FDA's approval for FemaSeed, Femasys can now move forward with commercialization, positioning itself in the rapidly growing infertility market. Approximately 10 million women in the U.S. face infertility issues, underscoring the significance of this development.
Kathy Lee-Sepsick, Femasys' founder, president, and CEO, expressed her excitement about the FDA approval, highlighting, “This FDA 510(k) Clearance of FemaSeed demonstrates our successful collaborative efforts with the FDA to bring forward new technology that will address the significant unmet need for less burdensome infertility treatments.”
The FDA's approval triggered an incredible surge in FEMY stock trading. Over 9.8 million shares, well above the average daily trading volume of approximately 3.3 million shares, have been exchanged as of this moment. Demonstrating the magnitude of this surge, FEMY stock soared by an astonishing 180.9% during Tuesday morning's trading session, offsetting a challenging year-to-date performance where the stock closed out Monday down by 63.2%.
Femasys Inc.'s historic 600%+ surge, fueled by the FDA approval for FemaSeed, has set the day trading community abuzz. The heightened volatility and price movements have laid the foundation for potential profits and exhilarating trading opportunities. However, prudent risk management and a strategic approach are essential for day traders looking to capitalize on this extraordinary market movement.
Wishing you all profitable trades and success in your endeavors.
See you tomorrow in my CyberGroup Live Trading room (Open Monday thru Friday from 7:45am - 4:30pm EST)
If you aren't already a member, you can sign up today at https://ctu.co/trial
Happy Trading,
Fausto Pugliese
Founder & CEO
Cyber Trading University
Privacy Policy – Terms of Use and Disclosures – Contact Us
[email protected] Call Us (877) 702-9237
CyberTradingUniversity.com is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. In addition, owners, employees, or representatives of Cyber Trading University are not investment advisors or registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.
IMPORTANT NOTICE! No representation is being made that using this strategy or any trading methodology will be profitable. Past performance is not necessarily indicative of future results. There is substantial risk associated with equities trading of securities and options. Trading securities is not for everyone. Disclaimer: Day Trading, Swing trading, Stock Trading, Futures, Options, and Currency trading all have large potential rewards, but also large potential risk. You should be aware of the risks and accept them in order to invest in these markets. Do not trade with money you cannot afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures, options, or currencies. No representation or promise is being made that anyone is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading methodology is not necessarily a guarantee of future results.
Visit our website below to read the full disclaimer.
https://cybertradinguniversity.com/terms-of-use-disclosures/
Risk Disclosure
This site is for educational purposes only. Past results are not indicative of future returns.
Risk Disclosure: Futures and forex trading contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results.
Hypothetical Performance Disclosure
Hypothetical performance results have many inherent limitations, some of which are described below. no representation is being made that any account will or is likely to achieve profits or losses similar to those shown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted for in the preparation of hypothetical performance results and all which can adversely affect trading results.
Testimonials Disclosure
Testimonials appearing on this website may not be representative of other clients or customers and is not a guarantee of future performance or success.
Partner Disclosures
TD Ameritrade, Inc. and Cyber Trading University are separate, unaffiliated companies and are not responsible for each other’s services and products.